Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A UCLA study has outlined a new framework that researchers say would improve the predictive power of genetics to determine ...
A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would ...
An analysis of more than 1,300 stroke survivors found that women were less likely than their male counterparts to take ...
Women who have had a stroke may be less likely than men to take medications to prevent a second stroke, with Mexican American women reporting the highest rates of nonadherence, according to new ...
An analysis of more than 1,300 stroke survivors found that women were less likely than their male counterparts to take ...
A UCLA study has outlined a new framework that researchers say would improve predictive power ... Researchers analyzed how their genetic makeups impacted their response to four of the most commonly ...
Esperion files new drug submissions in Canada for Nexletol and Nexlizet as a treatment for reducing bad cholesterol and ...
Esperion (ESPR) has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications ...
Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...
Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...
including Non-Alcoholic Steatohepatitis (NASH), fibrosis, and eventually cirrhosis. NAFLD is considered the hepatic ...